We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Fox Class A
FOXA
$24.2B
| $7.19M | 0.06% |
196,319
+146,318
| +293% | +$5.38M |
|
377
Global Payments
GPN
$23.9B
| $7.19M | 0.06% |
44,900
-100,674
| -69% | -$15M |
|
|
K
378
DELISTED
Kellanova
K
| $7.15M | 0.06% |
+142,202
| New | +$7.55M |
|
379
KB Home
KBH
$3.54B
| $7.12M | 0.06% |
276,695
-62,592
| -18% | -$1.61M |
|
|
CCX.U
380
DELISTED
Churchill Capital Corp II
CCX.U
| $7.11M | 0.06% |
+700,000
| New | +$7.1M |
|
|
DPHCU
381
DELISTED
DiamondPeak Holdings Corp. Units
DPHCU
| $7.07M | 0.06% |
700,000
| – | – |
|
382
AerCap
AER
$24.3B
| $7.03M | 0.06% |
+135,067
| New | +$6.62M |
|
383
Goodyear
GT
$2.12B
| $7.01M | 0.06% |
+458,185
| New | +$7.73M |
|
|
ACAMU
384
DELISTED
Acamar Partners Acquisition Corp Units
ACAMU
| $6.99M | 0.06% |
700,000
| – | – |
|
385
Polaris
PII
$4.07B
| $6.93M | 0.06% |
75,935
+75,128
| +9,310% | +$6.84M |
|
|
CMA
386
DELISTED
Comerica
CMA
| $6.92M | 0.06% |
+95,186
| New | +$7.07M |
|
|
GLUU
387
DELISTED
Glu Mobile Inc.
GLUU
| $6.88M | 0.06% |
+958,889
| New | +$8.81M |
|
|
SNV
388
DELISTED
Synovus
SNV
| $6.86M | 0.06% |
195,986
-149,466
| -43% | -$5.2M |
|
389
Kura Oncology
KURA
$826M
| $6.85M | 0.06% |
347,698
+325,258
| +1,449% | +$5.4M |
|
390
Webster Financial
WBS
$12.5B
| $6.84M | 0.06% |
143,194
+142,301
| +15,935% | +$7.09M |
|
391
United Airlines
UAL
$40.2B
| $6.83M | 0.06% |
77,959
+15,449
| +25% | +$1.31M |
|
|
DMS
392
DELISTED
Digital Media Solutions, Inc.
DMS
| $6.8M | 0.06% |
+44,176
| New | +$6.81M |
|
393
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.06B
| $6.78M | 0.06% |
62,249
+482
| +0.8% | +$52K |
|
394
National Health Investors
NHI
$3.81B
| $6.78M | 0.06% |
+86,890
| New | +$6.75M |
|
|
GOGL
395
DELISTED
Golden Ocean Group
GOGL
| $6.76M | 0.06% |
1,168,319
+294,329
| +34% | +$1.54M |
|
396
MillerKnoll
MLKN
$1.61B
| $6.74M | 0.06% |
+150,846
| New | +$5.71M |
|
|
CONN
397
DELISTED
Conn's Inc.
CONN
| $6.73M | 0.06% |
377,650
-397,733
| -51% | -$8.74M |
|
398
Veracyte
VCYT
$4.44B
| $6.72M | 0.06% |
235,645
+158,574
| +206% | +$3.96M |
|
399
Bio-Rad Laboratories Class A
BIO
$8.86B
| $6.71M | 0.06% |
+21,475
| New | +$6.43M |
|
400
East-West Bancorp
EWBC
$18B
| $6.66M | 0.05% |
+142,421
| New | +$6.82M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.